Delivery Order SPE2DB20D3103-SPE2DB22FL9M3
Award Date 12/13/21
Potential Completion Date 12/14/21
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Vimpat 50 mg tablets, a pharmaceutical product. The contract has a ceiling value of $1,514.70 and was awarded on June 22, 2022, with a completion date of June 23, 2022. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Vimpat 100 mg tablets. The contract has a ceiling value of $5,789.37 and an ultimate completion date of June 24, 2022. It is a firm fixed price contract and was not set aside for any specific business type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds several indefinite delivery contracts (IDCs) with the DLA and...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Vimpat 200 mg tablets. The firm-fixed-price contract, valued at $1,310.94, is a task order under a larger Indefinite Delivery Contract (IDC) held by the parent company, Cencora, Inc., doing business as AmerisourceBergen. The IDC, valued at up to $999,999,999.00, serves as the primary vehicle for AmerisourceBergen to provide a comprehensive...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,500.96 issued by the Defense Logistics Agency (DLA). The contract is for the delivery of Vimpat 200 mg tablets, a pharmaceutical product used for medical treatment. The contract has a completion date of December 13, 2021 and is a firm-fixed-price delivery order. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 60 tablets of the drug Vimpat 200 mg, with a total ceiling value of $2,070.40 and a completion date of July 16, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of the pharmaceutical product Vimpat 200 mg tablets. The contract, valued at $1,071.74, is a firm-fixed-price delivery order with a completion date of November 23, 2021. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of Vimpat 100 mg tablets, a pharmaceutical product used to treat certain types of seizures. The contract has a ceiling value of $2,688.95 and a final completion date of June 13, 2024. It is a firm-fixed-price contract with no set-aside designation. Amerisourcebergen is a major pharmaceutical distribution company that has...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,840.98, is for the supply of Vimpat 100 mg tablets to support military healthcare programs. It is a firm fixed-price contract with a period of performance through February 2024. The contract was not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug Corp...
- This federal contract award is for the delivery of Vimpat 10 mg/ml solution, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a ceiling value of $3,147.26 and is a firm-fixed-price delivery order, with a completion date of February 15, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Vimpat 100 mg tablets. The $1,415.46 firm fixed-price contract has an ultimate completion date of August 22, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...